
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.200 | 4.360 | 0.160 |
Shares | 95.800 | 95.800 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.984 | 16.728 |
Price to Book | 2.316 | 2.412 |
Price to Sales | 1.684 | 1.736 |
Price to Cash Flow | 12.273 | 11.215 |
Dividend Yield | 2.943 | 2.937 |
5 Years Earnings Growth | 8.102 | 9.296 |
Name | Net % | Category Average |
---|---|---|
Industrials | 39.940 | 33.669 |
Healthcare | 16.390 | 14.747 |
Financial Services | 14.410 | 18.093 |
Technology | 12.230 | 9.271 |
Consumer Defensive | 9.280 | 7.967 |
Consumer Cyclical | 3.980 | 5.829 |
Basic Materials | 3.760 | 5.847 |
Number of long holdings: 37
Number of short holdings: 14
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.40 | 432.9 | -1.32% | |
Sandvik AB | SE0000667891 | 5.52 | 215.80 | -0.92% | |
SEB A | SE0000148884 | 5.38 | 158.00 | +0.41% | |
Volvo B | SE0000115446 | 4.98 | 278.20 | -0.43% | |
Hexagon B | SE0015961909 | 4.62 | 100.93 | +0.77% | |
Kesko | FI0009000202 | 4.49 | 20.28 | +1.00% | |
DnB | NO0010161896 | 4.35 | 266.80 | +1.48% | |
Essity B | SE0009922164 | 4.34 | 270.20 | -0.92% | |
AstraZeneca | GB0009895292 | 4.29 | 10,022.0 | -1.55% | |
Beijer Ref | SE0015949748 | 4.07 | 152.40 | -0.62% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 128.87B | -14.52 | 7.67 | 9.72 | ||
Handelsbanken Global Tema (A1 SEK) | 45.85B | -17.31 | 3.88 | 9.48 | ||
Handelsbanken Global Tema (B1 SEK) | 45.85B | -17.31 | 3.88 | - | ||
SE0010127894 | 40.4B | -6.75 | 3.56 | - | ||
Handelsbanken Multi Asset 50 A1 S | 30.55B | -6.03 | 3.02 | 3.98 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review